# Octapharma Plasma Inc. – FDA Inspection, Mar 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/b34ad25c-567f-4cde-86cd-00f5bf6f8a19
Source feed: FDA_Inspections

> FDA inspection 1003089 of Octapharma Plasma Inc., March 02, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 606. Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1003089
- Company Name: Octapharma Plasma Inc.
- Inspection Date: 2017-03-02
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 2

## Related Documents

- FDA Inspection 1087869 - 2019-04-16
- FDA Inspection 941603 - 2015-09-09
- FDA Inspection 856909 - 2013-10-28
- FDA Inspection 761972 - 2011-12-22
- FDA Inspection 683029 - 2010-09-29

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/nancy-l-neiger/c3209528-eeb3-4a5f-88b1-f503798ed4c5)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/8cb7ed4e-1013-497a-a3da-c01096e19cb1

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d